Evolus (EOLS) Shares Outstanding (2017 - 2026)
Evolus' (EOLS) quarterly Shares Outstanding (Entity) came in at $65.8 million in Q1 2026, up 2.16% YoY from $64.4 million in Q1 2025, and up 1.28% on a QoQ basis from $65.0 million in Q4 2025.
Evolus (EOLS) Shares Outstanding (2017 - 2026) Analysis & Trends
Evolus (EOLS) has 10 years of Shares Outstanding (Entity) data on file, last reported at $65.8 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 2.16% year-over-year to $65.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $65.8 million (up 2.16% YoY) and the FY2025 annual result came in at $65.0 million, up 2.38% from the prior year.
- Shares Outstanding (Entity) grew to $65.8 million in Q1 2026, from $65.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $65.8 million in Q1 2026 to a low of $56.0 million in Q1 2022.
- A 5-year average of $60.6 million and a median of $62.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The widest YoY moves for Shares Outstanding (Entity): up 28.13% in 2022, down 1.13% in 2022.
- Tracing EOLS's Shares Outstanding (Entity) over 5 years: stood at $56.3 million in 2022, then rose by 2.77% to $57.8 million in 2023, then grew by 9.82% to $63.5 million in 2024, then grew by 2.38% to $65.0 million in 2025, then grew by 1.28% to $65.8 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $65.8 million (Q1 2026), $65.0 million (Q4 2025), and $64.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 832.44 Mn |
| 10 | Evolus | 553.80 Mn | 508.63 Mn | 57.18 Mn | 65.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 65.93 Mn |
| Mar 31, 2026 | 65.19 Mn |
| Dec 31, 2025 | 64.47 Mn |
| Sep 30, 2025 | 64.73 Mn |
| Jun 30, 2025 | 64.54 Mn |
| Mar 31, 2025 | 63.70 Mn |
| Dec 31, 2024 | 62.02 Mn |
| Sep 30, 2024 | 63.15 Mn |
| Jun 30, 2024 | 62.72 Mn |
| Mar 31, 2024 | 58.80 Mn |
| Dec 31, 2023 | 56.92 Mn |
| Sep 30, 2023 | 57.02 Mn |
| Jun 30, 2023 | 56.92 Mn |
| Mar 31, 2023 | 56.48 Mn |
| Dec 31, 2022 | 56.07 Mn |
| Sep 30, 2022 | 56.18 Mn |
| Jun 30, 2022 | 56.08 Mn |
| Mar 31, 2022 | 55.73 Mn |
| Dec 31, 2021 | 49.77 Mn |
| Sep 30, 2021 | 55.01 Mn |